Enochian BioSciences plunges as Hindenburg takes short position
** Gene therapy developer Enochian BioSciences Inc's shares
ENOB.O plunge 34.4% to $3.85 in afternoon trade
** Hindenburg Research tweets it is short on ENOB; will
release a report next week (https://bit.ly/3wR4WwI)
** Including session losses, stock down 56% YTD
** ENOB did not immediately respond to Reuters' request for
comment
(Reporting by Leroy Leo in Bengaluru)
((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing